Regulation & law · 19/10/2023

National Institute of Allergy and Infectious Diseases to Grant Exclusive Patent License to Leyden Laboratories for Human Monoclonal Antibodies Against Coronaviruses

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Leyden Laboratories B.V., a Dutch company, to use human monoclonal antibodies that target coronaviruses.